• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    NYSE Content Advisory: Pre-Market update + Wall Street braces for Nvidia's earnings

    8/27/25 8:55:00 AM ET
    $ABT
    $ICE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Investment Bankers/Brokers/Service
    Finance
    Get the next $ABT alert in real time by email

    NEW YORK, Aug. 27, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. 

    Ashley Mastronardi delivers the pre-market update on August 27th

    • Equities are up this morning as investors wait for chip giant Nvidia's Q2 earnings report. The company is set to release the earnings after market close this afternoon.
    • As the most heavily weighted company in the S&P 500 at more than 8%, Nvidia's results will likely be felt by investors throughout the rest of the week and provide insight into the level of demand for AI.
    • The major averages are coming off a day of fractional gains with investors shaking off President Trump's move to fire Fed Governor Lisa Cook ahead of the Fed's next policy meeting in Mid-September.

    Opening Bell

    Abbott (NYSE:ABT) and the Big Ten Conference are teaming up to address the worst blood shortage in a generation

    Closing Bell

    Van Eck celebrates the 70th anniversary of Van Eck and its first ETF listing

    Click here to download the NYSE TV App

    NYSE Logo (PRNewsfoto/New York Stock Exchange)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/nyse-content-advisory-pre-market-update--wall-street-braces-for-nvidias-earnings-302539974.html

    SOURCE New York Stock Exchange

    Get the next $ABT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABT
    $ICE

    CompanyDatePrice TargetRatingAnalyst
    Intercontinental Exchange Inc.
    $ICE
    10/13/2025$210.00Outperform → Strong Buy
    Raymond James
    Abbott Laboratories
    $ABT
    10/10/2025$145.00Buy
    The Benchmark Company
    Abbott Laboratories
    $ABT
    7/18/2025$145.00Hold → Buy
    Jefferies
    Abbott Laboratories
    $ABT
    6/16/2025$143.00Market Perform
    Leerink Partners
    Intercontinental Exchange Inc.
    $ICE
    10/14/2024$185.00Strong Buy → Outperform
    Raymond James
    Abbott Laboratories
    $ABT
    10/8/2024$130.00Outperform
    Oppenheimer
    Intercontinental Exchange Inc.
    $ICE
    9/27/2024$200.00Outperform
    RBC Capital Mkts
    Intercontinental Exchange Inc.
    $ICE
    9/26/2024$182.00Buy
    TD Cowen
    More analyst ratings

    $ABT
    $ICE
    SEC Filings

    View All

    SEC Form 144 filed by Intercontinental Exchange Inc.

    144 - Intercontinental Exchange, Inc. (0001571949) (Subject)

    12/5/25 4:24:53 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    Amendment: SEC Form SCHEDULE 13G/A filed by Intercontinental Exchange Inc.

    SCHEDULE 13G/A - Intercontinental Exchange, Inc. (0001571949) (Subject)

    12/3/25 11:12:52 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    Abbott Laboratories filed SEC Form 8-K: Temporary Suspension of Trading Under Registrant's Employee Benefit Plans, Financial Statements and Exhibits

    8-K - ABBOTT LABORATORIES (0000001800) (Filer)

    11/21/25 4:06:09 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    $ICE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    NYSE Content Advisory: Market Update + Target Opens Newly Transformed 'Target SoHo' in New York

    NEW YORK, Dec. 9, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily market update directly from the NYSE Trading Floor. Access today's NYSE market update for market insights as trading begins.  Kristen Scholer delivers the market update on December 9th Traders await the Federal Reserve's final interest rate decision of the year. Markets are pricing in with near certainty a 0.25% rate cut, following the Fed's two-day policy meeting that begins today, with the announcement expected Wednesday.NYSE-listed Target unveils a reimagined SoHo store led by incoming CEO Michael Fiddelke. The concept includes a beauty bar, selfie checkout, and curated

    12/9/25 11:38:00 AM ET
    $AUB
    $ICE
    Major Banks
    Finance
    Investment Bankers/Brokers/Service

    Expero to Deliver ICE's Market Data Through Digital Experiences

    This collaboration expands Expero's Connected Finance ecosystem with ICE's cross-asset data and analytics to power modern investor and advisor platforms HOUSTON, Dec. 9, 2025 /PRNewswire/ -- Expero, a leader in digital wealth technology and AI-driven user experiences, today announced an agreement with Intercontinental Exchange, Inc. (NYSE:ICE), a leading global provider of technology and data, to bring ICE's extensive cross-asset data and analytics into Expero's Connected Finance platform, enabling clients to integrate market data directly into trading, advisor and investor workflows using Expero's custom-built software components.

    12/9/25 8:30:00 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    Abbott's Lingo™ Now on Android™, Expanding Access to Real-Time Glucose Data

    Lingo, Abbott's first over-the-counter biowearable, expands to Android devicesContinuous glucose monitoring devices help people maintain healthy glucose levels, which are associated with better metabolic health and lower long-term risk of chronic conditionsNew data from Lingo users highlight how protein supplementation is linked to lower glucose in people who use continuous glucose monitors, especially for people with obesity, a group at higher risk for prediabetes, type 2 diabetes and other chronic conditionsABBOTT PARK, Ill., Dec. 8, 2025 /PRNewswire/ -- Abbott (NYSE:ABT) today announced that Lingo, an over-the-counter continuous glucose monitor (CGM) and app, is now available for Android

    12/8/25 9:00:00 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    $ICE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Intercontinental Exchange upgraded by Raymond James with a new price target

    Raymond James upgraded Intercontinental Exchange from Outperform to Strong Buy and set a new price target of $210.00

    10/13/25 8:40:25 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    The Benchmark Company initiated coverage on Abbott Labs with a new price target

    The Benchmark Company initiated coverage of Abbott Labs with a rating of Buy and set a new price target of $145.00

    10/10/25 8:35:50 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Abbott Labs upgraded by Jefferies with a new price target

    Jefferies upgraded Abbott Labs from Hold to Buy and set a new price target of $145.00

    7/18/25 7:54:43 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    $ICE
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 24, 2023 - FDA Approves New Therapy for Rare Form of Blood Cancers Called Myelodysplastic Syndromes

    For Immediate Release: October 24, 2023 Today, the U.S. Food and Drug Administration approved Tibsovo (ivosidenib) for the treatment of adult patients with relapsed or refractory (R/R) myelodysplastic syndromes (MDS) with an isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test. This is the first targeted therapy approved for this indication. The agency also approved the Abbott RealTime

    10/24/23 3:52:17 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    $ICE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Sprieser Judith A sold $584,440 worth of shares (3,700 units at $157.96), decreasing direct ownership by 20% to 14,469 units (SEC Form 4)

    4 - Intercontinental Exchange, Inc. (0001571949) (Issuer)

    12/9/25 4:30:04 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    President, NYSE Group Martin Lynn C gifted 396 shares, decreasing direct ownership by 0.67% to 59,033 units (SEC Form 4)

    4 - Intercontinental Exchange, Inc. (0001571949) (Issuer)

    12/8/25 4:30:08 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    Large owner Intercontinental Exchange, Inc. converted options into 465,890 shares (SEC Form 4)

    4 - Intercontinental Exchange, Inc. (0001571949) (Reporting)

    12/5/25 6:19:29 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    $ABT
    $ICE
    Leadership Updates

    Live Leadership Updates

    View All

    Abbott HeartMates Community Delivers Holiday Cheer in Hallmark Channel's New Movie "The More the Merrier"

    Movie to feature cameos from youth who have overcome significant heart health challenges and are part of the Abbott HeartMates community as well as professional football player and HeartMates ambassador Damar Hamlin "The More the Merrier" is the first Hallmark movie ever to include cameos from real-life individuals who have overcome cardiovascular challengesCharacter in the movie was inspired by Abbott HeartMates member Zeke Mankins, who has established a friendship with Hamlin through Hamlin's ambassador role for the HeartMates communityMovie premieres on Hallmark Channel on Nov. 28, 2025, during Hallmark's Merry Thanksgiving Weekend during "Countdown to Christmas"ABBOTT PARK, Ill., Nov. 4,

    11/4/25 9:00:00 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Lord Hill of Oareford Elected to Board of Directors of Intercontinental Exchange

    Intercontinental Exchange, Inc. (NYSE:ICE), a leading global provider of technology and data, today announced that its Board of Directors has elected The Rt. Hon. the Lord Hill of Oareford CBE (Lord Hill) as a new director, effective September 18, 2025. Lord Hill, who currently serves on the Board of Directors of ICE Endex Markets, a subsidiary of ICE, is also expected to join the Board of Directors of ICE Futures Europe subject to regulatory approval. "On behalf of the Board, I am pleased to welcome our colleague, Lord Hill, to his expanded role at ICE," said Jeffrey C. Sprecher, Founder, Chair and CEO of Intercontinental Exchange. "Lord Hill brings tremendous depth and breadth of experi

    9/18/25 4:15:00 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    NYSE Content Advisory: Pre-Market update + Fed Chair Jerome Powell Set to Deliver Jackson Hole Speech

    NEW YORK, Aug. 22, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Ashley Mastronardi delivers the pre-market update on August 22nd Markets are closely watching the Fed's economic policy symposium in Jackson Hole, where Chair Jerome Powell will speak at 10 a.m. ET.Nearly 70% of traders expect a Fed rate cut in September amid dual concerns about inflation and employment highlighted in the Fed's July meeting minutes.The Fed's July meeting minutes emphasized policymakers' concerns about both inflation ris

    8/22/25 8:55:00 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    $ABT
    $ICE
    Financials

    Live finance-specific insights

    View All

    Abbott to acquire Exact Sciences, a leader in large and fast-growing cancer screening and precision oncology diagnostics segments

    Acquisition adds a new growth vertical to Abbott's already high single-digit growth profile, gaining leadership in the fast-growing $60 billion U.S. cancer screening and precision oncology diagnostics segmentsAcquisition will uniquely position Abbott to transform cancer care, advancing earlier detection and optimizing treatment and monitoring to help millions more people live healthier livesExact Sciences' product lines feature advanced cancer screening and diagnostic solutions, including the market-leading Cologuard® and Oncotype DX® tests, and cutting-edge liquid biopsy tests for multi-cancer early detection and molecular residual disease testingAcquisition will be immediately accretive to

    11/20/25 7:30:00 AM ET
    $ABT
    $EXAS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical Specialities

    Intercontinental Exchange Approves Fourth Quarter Dividend of $0.48 per Share

    Intercontinental Exchange (NYSE:ICE), a leading global provider of technology and data, announced today a $0.48 per share dividend for the fourth quarter of 2025, which is up 7% from the $0.45 per share dividend paid in the fourth quarter of 2024. The cash dividend is payable on December 31, 2025 to stockholders of record as of December 16, 2025. The ex-dividend date is December 16, 2025. About Intercontinental Exchange Intercontinental Exchange, Inc. (NYSE:ICE) is a Fortune 500 company that designs, builds, and operates digital networks that connect people to opportunity. We provide financial technology and data services across major asset classes helping our customers access mission-c

    10/30/25 7:35:00 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    Intercontinental Exchange Reports Strong Third Quarter 2025

    Intercontinental Exchange (NYSE:ICE): 3Q25 net revenues of $2.4 billion, +3% y/y   3Q25 GAAP diluted earnings per share (EPS) of $1.42, +25% y/y   3Q25 adj. diluted EPS of $1.71, +10% y/y   3Q25 operating income of $1.2 billion, +6% y/y; adj. operating income of $1.4 billion, +3% y/y   3Q25 operating margin of 49%; adj. operating margin of 59%   Through September 30, 2025, returned over $1.7 billion to stockholders, including $894 million in share repurchases   Jeffrey C. Sprecher,ICE Chair & Chief Executive Officer, said,"We are pleased to report our third quarter results, which extend our track record of revenue and earnings per

    10/30/25 7:30:00 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    $ABT
    $ICE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Abbott Laboratories (Amendment)

    SC 13G/A - ABBOTT LABORATORIES (0000001800) (Subject)

    2/13/24 4:55:58 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G/A filed by Intercontinental Exchange Inc. (Amendment)

    SC 13G/A - Intercontinental Exchange, Inc. (0001571949) (Subject)

    2/13/24 1:23:13 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    SEC Form SC 13G/A filed by Abbott Laboratories (Amendment)

    SC 13G/A - ABBOTT LABORATORIES (0000001800) (Subject)

    2/9/23 10:54:50 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care